MARSH & MCLENNAN COS (MRSH) Stock Fundamental Analysis

NYSE:MRSH • US5717481023

174.06 USD
+0.73 (+0.42%)
At close: Feb 13, 2026
174.06 USD
0 (0%)
After Hours: 2/13/2026, 8:26:58 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to MRSH. MRSH was compared to 149 industry peers in the Insurance industry. While MRSH has a great profitability rating, there are some minor concerns on its financial health. MRSH is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year MRSH was profitable.
  • MRSH had a positive operating cash flow in the past year.
  • MRSH had positive earnings in each of the past 5 years.
  • MRSH had a positive operating cash flow in each of the past 5 years.
MRSH Yearly Net Income VS EBIT VS OCF VS FCFMRSH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

1.2 Ratios

  • With an excellent Return On Assets value of 7.09%, MRSH belongs to the best of the industry, outperforming 90.60% of the companies in the same industry.
  • MRSH has a better Return On Equity (27.16%) than 93.96% of its industry peers.
  • With an excellent Return On Invested Capital value of 13.16%, MRSH belongs to the best of the industry, outperforming 95.97% of the companies in the same industry.
  • MRSH had an Average Return On Invested Capital over the past 3 years of 13.42%. This is in line with the industry average of 14.95%.
Industry RankSector Rank
ROA 7.09%
ROE 27.16%
ROIC 13.16%
ROA(3y)7.36%
ROA(5y)7.63%
ROE(3y)29.47%
ROE(5y)29.19%
ROIC(3y)13.42%
ROIC(5y)13.17%
MRSH Yearly ROA, ROE, ROICMRSH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • The Profit Margin of MRSH (15.42%) is better than 79.19% of its industry peers.
  • MRSH's Profit Margin has improved in the last couple of years.
  • With an excellent Operating Margin value of 24.22%, MRSH belongs to the best of the industry, outperforming 83.22% of the companies in the same industry.
  • In the last couple of years the Operating Margin of MRSH has grown nicely.
Industry RankSector Rank
OM 24.22%
PM (TTM) 15.42%
GM N/A
OM growth 3Y0.51%
OM growth 5Y3.67%
PM growth 3Y1.56%
PM growth 5Y5.67%
GM growth 3YN/A
GM growth 5YN/A
MRSH Yearly Profit, Operating, Gross MarginsMRSH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

5

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), MRSH is creating some value.
  • MRSH has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for MRSH has been reduced compared to 5 years ago.
  • The debt/assets ratio for MRSH has been reduced compared to a year ago.
MRSH Yearly Shares OutstandingMRSH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M
MRSH Yearly Total Debt VS Total AssetsMRSH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B 50B

2.2 Solvency

  • MRSH has a debt to FCF ratio of 3.92. This is a good value and a sign of high solvency as MRSH would need 3.92 years to pay back of all of its debts.
  • MRSH has a Debt to FCF ratio of 3.92. This is comparable to the rest of the industry: MRSH outperforms 43.62% of its industry peers.
  • A Debt/Equity ratio of 1.20 is on the high side and indicates that MRSH has dependencies on debt financing.
  • MRSH has a Debt to Equity ratio of 1.20. This is amonst the worse of the industry: MRSH underperforms 88.59% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.2
Debt/FCF 3.92
Altman-Z N/A
ROIC/WACC1.7
WACC7.75%
MRSH Yearly LT Debt VS Equity VS FCFMRSH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.3 Liquidity

  • A Current Ratio of 1.10 indicates that MRSH should not have too much problems paying its short term obligations.
  • MRSH has a better Current ratio (1.10) than 81.21% of its industry peers.
  • A Quick Ratio of 1.10 indicates that MRSH should not have too much problems paying its short term obligations.
  • MRSH has a better Quick ratio (1.10) than 81.21% of its industry peers.
Industry RankSector Rank
Current Ratio 1.1
Quick Ratio 1.1
MRSH Yearly Current Assets VS Current LiabilitesMRSH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 10.80% over the past year.
  • The Earnings Per Share has been growing by 14.43% on average over the past years. This is quite good.
  • Looking at the last year, MRSH shows a quite strong growth in Revenue. The Revenue has grown by 10.32% in the last year.
  • MRSH shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.39% yearly.
EPS 1Y (TTM)10.8%
EPS 3Y12.54%
EPS 5Y14.43%
EPS Q2Q%13.37%
Revenue 1Y (TTM)10.32%
Revenue growth 3Y9.2%
Revenue growth 5Y9.39%
Sales Q2Q%8.7%

3.2 Future

  • MRSH is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.85% yearly.
  • Based on estimates for the next years, MRSH will show a small growth in Revenue. The Revenue will grow by 4.90% on average per year.
EPS Next Y8.68%
EPS Next 2Y8.91%
EPS Next 3Y8.87%
EPS Next 5Y9.85%
Revenue Next Year5.05%
Revenue Next 2Y5.11%
Revenue Next 3Y5.24%
Revenue Next 5Y4.9%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MRSH Yearly Revenue VS EstimatesMRSH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B
MRSH Yearly EPS VS EstimatesMRSH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5 10

2

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 17.85, which indicates a rather expensive current valuation of MRSH.
  • MRSH's Price/Earnings ratio is a bit more expensive when compared to the industry. MRSH is more expensive than 67.11% of the companies in the same industry.
  • MRSH is valuated rather cheaply when we compare the Price/Earnings ratio to 26.68, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 16.43 indicates a correct valuation of MRSH.
  • Based on the Price/Forward Earnings ratio, MRSH is valued a bit more expensive than 65.77% of the companies in the same industry.
  • MRSH is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 28.06, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 17.85
Fwd PE 16.43
MRSH Price Earnings VS Forward Price EarningsMRSH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • MRSH's Enterprise Value to EBITDA is on the same level as the industry average.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of MRSH indicates a slightly more expensive valuation: MRSH is more expensive than 60.40% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 16.88
EV/EBITDA 13.61
MRSH Per share dataMRSH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • MRSH has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.06
PEG (5Y)1.24
EPS Next 2Y8.91%
EPS Next 3Y8.87%

4

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 2.08%, MRSH has a reasonable but not impressive dividend return.
  • MRSH's Dividend Yield is comparable with the industry average which is at 2.67.
  • MRSH's Dividend Yield is comparable with the S&P500 average which is at 1.84.
Industry RankSector Rank
Dividend Yield 2.08%

5.2 History

  • The dividend of MRSH is nicely growing with an annual growth rate of 13.29%!
  • MRSH has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)13.29%
Div Incr YearsN/A
Div Non Decr YearsN/A
MRSH Yearly Dividends per shareMRSH Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 2026 1 2 3

5.3 Sustainability

  • 40.84% of the earnings are spent on dividend by MRSH. This is a bit on the high side, but may be sustainable.
  • MRSH's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP40.84%
EPS Next 2Y8.91%
EPS Next 3Y8.87%
MRSH Yearly Income VS Free CF VS DividendMRSH Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B
MRSH Dividend Payout.MRSH Dividend Payout, showing the Payout Ratio.MRSH Dividend Payout.PayoutRetained Earnings

MARSH & MCLENNAN COS

NYSE:MRSH (2/13/2026, 8:26:58 PM)

After market: 174.06 0 (0%)

174.06

+0.73 (+0.42%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)01-29
Earnings (Next)04-15
Inst Owners91.61%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap84.42B
Revenue(TTM)26.98B
Net Income(TTM)4.16B
Analysts69.33
Price Target214.57 (23.27%)
Short Float %1%
Short Ratio2.19
Dividend
Industry RankSector Rank
Dividend Yield 2.08%
Yearly Dividend3.48
Dividend Growth(5Y)13.29%
DP40.84%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-Date01-29
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.53%
Min EPS beat(2)1.65%
Max EPS beat(2)5.41%
EPS beat(4)3
Avg EPS beat(4)1.69%
Min EPS beat(4)-0.63%
Max EPS beat(4)5.41%
EPS beat(8)5
Avg EPS beat(8)1.23%
EPS beat(12)9
Avg EPS beat(12)1.4%
EPS beat(16)12
Avg EPS beat(16)1.55%
Revenue beat(2)0
Avg Revenue beat(2)-1.39%
Min Revenue beat(2)-1.52%
Max Revenue beat(2)-1.26%
Revenue beat(4)0
Avg Revenue beat(4)-1.58%
Min Revenue beat(4)-2.27%
Max Revenue beat(4)-1.26%
Revenue beat(8)1
Avg Revenue beat(8)-1.54%
Revenue beat(12)2
Avg Revenue beat(12)-1.16%
Revenue beat(16)2
Avg Revenue beat(16)-1.56%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)1.83%
EPS NQ rev (3m)N/A
EPS NY rev (1m)1.92%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)1.03%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.03%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 17.85
Fwd PE 16.43
P/S 3.13
P/FCF 16.88
P/OCF 15.95
P/B 5.51
P/tB N/A
EV/EBITDA 13.61
EPS(TTM)9.75
EY5.6%
EPS(NY)10.6
Fwd EY6.09%
FCF(TTM)10.31
FCFY5.92%
OCF(TTM)10.91
OCFY6.27%
SpS55.63
BVpS31.58
TBVpS-28.39
PEG (NY)2.06
PEG (5Y)1.24
Graham Number83.23
Profitability
Industry RankSector Rank
ROA 7.09%
ROE 27.16%
ROCE 17.36%
ROIC 13.16%
ROICexc 14.17%
ROICexgc 84.24%
OM 24.22%
PM (TTM) 15.42%
GM N/A
FCFM 18.54%
ROA(3y)7.36%
ROA(5y)7.63%
ROE(3y)29.47%
ROE(5y)29.19%
ROIC(3y)13.42%
ROIC(5y)13.17%
ROICexc(3y)14.71%
ROICexc(5y)14.27%
ROICexgc(3y)79.22%
ROICexgc(5y)69.06%
ROCE(3y)17.7%
ROCE(5y)17.38%
ROICexgc growth 3Y10.81%
ROICexgc growth 5Y14.57%
ROICexc growth 3Y-2.07%
ROICexc growth 5Y5.54%
OM growth 3Y0.51%
OM growth 5Y3.67%
PM growth 3Y1.56%
PM growth 5Y5.67%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 1.2
Debt/FCF 3.92
Debt/EBITDA 2.46
Cap/Depr 31.98%
Cap/Sales 1.08%
Interest Coverage 250
Cash Conversion 71.07%
Profit Quality 120.22%
Current Ratio 1.1
Quick Ratio 1.1
Altman-Z N/A
F-Score6
WACC7.75%
ROIC/WACC1.7
Cap/Depr(3y)45.02%
Cap/Depr(5y)50.96%
Cap/Sales(3y)1.43%
Cap/Sales(5y)1.72%
Profit Quality(3y)106.74%
Profit Quality(5y)103.48%
High Growth Momentum
Growth
EPS 1Y (TTM)10.8%
EPS 3Y12.54%
EPS 5Y14.43%
EPS Q2Q%13.37%
EPS Next Y8.68%
EPS Next 2Y8.91%
EPS Next 3Y8.87%
EPS Next 5Y9.85%
Revenue 1Y (TTM)10.32%
Revenue growth 3Y9.2%
Revenue growth 5Y9.39%
Sales Q2Q%8.7%
Revenue Next Year5.05%
Revenue Next 2Y5.11%
Revenue Next 3Y5.24%
Revenue Next 5Y4.9%
EBIT growth 1Y5.3%
EBIT growth 3Y9.75%
EBIT growth 5Y13.41%
EBIT Next Year21.42%
EBIT Next 3Y10.36%
EBIT Next 5Y8.64%
FCF growth 1Y25.46%
FCF growth 3Y18.64%
FCF growth 5Y10.51%
OCF growth 1Y23.01%
OCF growth 3Y15.16%
OCF growth 5Y9.37%

MARSH & MCLENNAN COS / MRSH FAQ

Can you provide the ChartMill fundamental rating for MARSH & MCLENNAN COS?

ChartMill assigns a fundamental rating of 5 / 10 to MRSH.


What is the valuation status for MRSH stock?

ChartMill assigns a valuation rating of 2 / 10 to MARSH & MCLENNAN COS (MRSH). This can be considered as Overvalued.


What is the profitability of MRSH stock?

MARSH & MCLENNAN COS (MRSH) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for MRSH stock?

The Price/Earnings (PE) ratio for MARSH & MCLENNAN COS (MRSH) is 17.85 and the Price/Book (PB) ratio is 5.51.


Can you provide the expected EPS growth for MRSH stock?

The Earnings per Share (EPS) of MARSH & MCLENNAN COS (MRSH) is expected to grow by 8.68% in the next year.